CH611630A5 - Process for the preparation of steroid alkyl ethers - Google Patents
Process for the preparation of steroid alkyl ethersInfo
- Publication number
- CH611630A5 CH611630A5 CH1733774A CH1733774A CH611630A5 CH 611630 A5 CH611630 A5 CH 611630A5 CH 1733774 A CH1733774 A CH 1733774A CH 1733774 A CH1733774 A CH 1733774A CH 611630 A5 CH611630 A5 CH 611630A5
- Authority
- CH
- Switzerland
- Prior art keywords
- steroid
- base
- sulfate
- dialkyl sulfate
- starting steroid
- Prior art date
Links
- -1 steroid alkyl ethers Chemical class 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 title claims description 52
- 150000003431 steroids Chemical class 0.000 claims abstract description 75
- 239000002904 solvent Substances 0.000 claims abstract description 39
- 238000006243 chemical reaction Methods 0.000 claims abstract description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 15
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 150000004292 cyclic ethers Chemical class 0.000 claims abstract description 11
- 150000002576 ketones Chemical class 0.000 claims abstract description 11
- 150000008050 dialkyl sulfates Chemical class 0.000 claims description 62
- 239000002585 base Substances 0.000 claims description 53
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 36
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 29
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 24
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 claims description 18
- 229960003399 estrone Drugs 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 15
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims description 12
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 claims description 9
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 9
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 9
- 229930182833 estradiol Natural products 0.000 claims description 9
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 claims description 9
- 239000011541 reaction mixture Substances 0.000 claims description 9
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 claims description 8
- PDRGHUMCVRDZLQ-UHFFFAOYSA-N d-equilenin Natural products OC1=CC=C2C(CCC3(C4CCC3=O)C)=C4C=CC2=C1 PDRGHUMCVRDZLQ-UHFFFAOYSA-N 0.000 claims description 8
- PDRGHUMCVRDZLQ-WMZOPIPTSA-N equilenin Chemical compound OC1=CC=C2C(CC[C@]3([C@H]4CCC3=O)C)=C4C=CC2=C1 PDRGHUMCVRDZLQ-WMZOPIPTSA-N 0.000 claims description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 7
- 229960002568 ethinylestradiol Drugs 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 claims description 5
- 229940008406 diethyl sulfate Drugs 0.000 claims description 5
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- LMEDOLJKVASKTP-UHFFFAOYSA-N dibutyl sulfate Chemical compound CCCCOS(=O)(=O)OCCCC LMEDOLJKVASKTP-UHFFFAOYSA-N 0.000 claims description 4
- GAFRWLVTHPVQGK-UHFFFAOYSA-N dipentyl sulfate Chemical compound CCCCCOS(=O)(=O)OCCCCC GAFRWLVTHPVQGK-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000006266 etherification reaction Methods 0.000 claims description 3
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 239000003637 basic solution Substances 0.000 claims description 2
- 239000006227 byproduct Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229910052920 inorganic sulfate Inorganic materials 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract description 6
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 10
- 229960005309 estradiol Drugs 0.000 description 9
- BCWWDWHFBMPLFQ-VXNCWWDNSA-N (8r,9s,13s,14s)-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-one Chemical compound C1C[C@]2(C)C(=O)CC[C@H]2[C@@H]2CCC3=CC(OC)=CC=C3[C@H]21 BCWWDWHFBMPLFQ-VXNCWWDNSA-N 0.000 description 8
- 239000013078 crystal Substances 0.000 description 6
- 229960001348 estriol Drugs 0.000 description 6
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 5
- AIBFRTWVQFOKIS-DRMAHVMPSA-N 3-Hydroxy-1-methylestra-1,3,5(10)-trien-17-one Chemical compound C([C@]1(C)C(=O)CC[C@H]1[C@@H]1CC2)C[C@@H]1C1=C2C=C(O)C=C1C AIBFRTWVQFOKIS-DRMAHVMPSA-N 0.000 description 4
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KJDGFQJCHFJTRH-YONAWACDSA-N 16-Ketoestradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](C(=O)C4)O)[C@@H]4[C@@H]3CCC2=C1 KJDGFQJCHFJTRH-YONAWACDSA-N 0.000 description 1
- KJDGFQJCHFJTRH-UHFFFAOYSA-N 16-Ketoestradiol Natural products OC1=CC=C2C3CCC(C)(C(C(=O)C4)O)C4C3CCC2=C1 KJDGFQJCHFJTRH-UHFFFAOYSA-N 0.000 description 1
- WNYWRAYXFFPPGN-QDTBLXIISA-N 4-Nitroestrone Chemical compound C1=CC(O)=C([N+]([O-])=O)C2=C1[C@H]1CC[C@](C)(C(CC3)=O)[C@@H]3[C@@H]1CC2 WNYWRAYXFFPPGN-QDTBLXIISA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- WKRLQDKEXYKHJB-UHFFFAOYSA-N Equilin Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3=CCC2=C1 WKRLQDKEXYKHJB-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- YWAAKSBJISUYNU-UHFFFAOYSA-N buta-1,2-dien-1-one Chemical compound CC=C=C=O YWAAKSBJISUYNU-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- WKRLQDKEXYKHJB-HFTRVMKXSA-N equilin Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4C3=CCC2=C1 WKRLQDKEXYKHJB-HFTRVMKXSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP741184A JPS5327267B2 (fr) | 1973-12-29 | 1973-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH611630A5 true CH611630A5 (en) | 1979-06-15 |
Family
ID=11494353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1733774A CH611630A5 (en) | 1973-12-29 | 1974-12-27 | Process for the preparation of steroid alkyl ethers |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3939186A (fr) |
| JP (1) | JPS5327267B2 (fr) |
| CH (1) | CH611630A5 (fr) |
| DE (1) | DE2460657C3 (fr) |
| FR (1) | FR2256176B1 (fr) |
| GB (1) | GB1444320A (fr) |
| NL (1) | NL7416958A (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4340602A (en) * | 1978-10-18 | 1982-07-20 | Wayne State University | Compositions inhibiting estrogen sulfotransferase activity |
| FR2693728B1 (fr) * | 1992-07-17 | 1994-09-23 | Orsan | Procédé de fabrication de cyclodextrines partiellement méthylées et composés obtenus. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB813845A (en) * | 1955-08-01 | 1959-05-27 | Lasdon Foundation Inc | Improvements in cyclopentanophenanthrene compounds |
-
1973
- 1973-12-29 JP JP741184A patent/JPS5327267B2/ja not_active Expired
-
1974
- 1974-12-06 US US05/530,151 patent/US3939186A/en not_active Expired - Lifetime
- 1974-12-20 FR FR7442335A patent/FR2256176B1/fr not_active Expired
- 1974-12-20 DE DE2460657A patent/DE2460657C3/de not_active Expired
- 1974-12-24 GB GB5566874A patent/GB1444320A/en not_active Expired
- 1974-12-27 CH CH1733774A patent/CH611630A5/de not_active IP Right Cessation
- 1974-12-27 NL NL7416958A patent/NL7416958A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2460657A1 (de) | 1975-07-10 |
| US3939186A (en) | 1976-02-17 |
| FR2256176B1 (fr) | 1979-07-06 |
| FR2256176A1 (fr) | 1975-07-25 |
| NL7416958A (nl) | 1975-07-01 |
| DE2460657C3 (de) | 1979-10-04 |
| DE2460657B2 (de) | 1979-02-22 |
| JPS5096557A (fr) | 1975-07-31 |
| GB1444320A (en) | 1976-07-28 |
| JPS5327267B2 (fr) | 1978-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1468897A1 (de) | Verfahren zur Herstellung von 13,17-Diaethyl-18,19-dinortestosteron | |
| CH517725A (de) | Verfahren zur Herstellung von 7a-Methylsteroiden | |
| DE2460657C3 (de) | Verfahren zur Herstellung von Steroidalkyläthern | |
| DE1468410A1 (de) | Verfahren zur Herstellung von 16-Methylensteroiden | |
| DE1172671B (de) | Verfahren zur Herstellung von 17ª-Hydroxy-androstan-(3, 2-c)-pyrazol oder eines 17ª-Hydroxy-17ª-niederes-Alkyl-androstan-(3, 2-c)-pyrazols | |
| DE2729501A1 (de) | Verfahren zur herstellung von 17beta-hydroxy-3-oxo-17alpha-pregn-4- en-21-carbonsaeure-gamma-lacton | |
| EP0538348A1 (fr) | PROCEDE DE PRODUCTION DE 17-g(a)-CYANOMETHYL-17-g(b)-HYDROXYSTEROIDES INSATURES. | |
| CH493501A (de) | Verfahren zur Herstellung von Steroidverbindungen | |
| CH537913A (de) | Verfahren zur Herstellung von 5(10)-Keto-19-nor-steroiden | |
| DE1165595B (de) | Verfahren zur Herstellung von Triamcinolonacetonid-21-hemisuccinat und dessen Salzen | |
| DE2246867A1 (de) | Tetrahydroxy-bicyclo- eckige klammer auf 3.3.0 eckige klammer zu -octane | |
| DE2238220A1 (de) | Verfahren zur herstellung von 3-(3beta, 17beta-dihydroxyandrost-5-en17alpha-yl)-propionsaeure-gamma-lacton | |
| DE959187C (de) | Verfahren zur Herstellung von 11-Keto-17 ª‡-aethinyltestosteron bzw. von 11ª‰-Oxy-17-ª‡-aethinyltestosteron | |
| DE19631543C1 (de) | Verfahren zur Herstellung von 3-Sulfatoxy-estra-1,3,5(10)-trien-Derivaten I | |
| DE1187236B (de) | Verfahren zur Herstellung von 17beta-Aminosteroiden | |
| DE1593213C3 (de) | Verfahren zur Herstellung von Steroidazinen Ausscheidung aus 1248653 | |
| DE864254C (de) | Verfahren zur Herstellung von Reduktinsaeure | |
| AT219204B (de) | Verfahren zur Herstellung von 3-Alkoxy-19-nor-δ<2,5(10)> -androstadien-17-on | |
| AT233179B (de) | Verfahren zur Herstellung des neuen 3β-Hydroxy- und 3β-Acyloxy-6, 16-dimethylpregna-5, 16-dien-20-one | |
| DE2360176A1 (de) | Verfahren zur herstellung von 2,4,6- substituierten cyclohexan-1,3,5-triolen | |
| DE2001262A1 (de) | 19-Homosteroide | |
| DE1793344A1 (de) | 2-Halogen-18-methyl-1-androstene | |
| CH348965A (de) | Verfahren zur Herstellung von 11 -Oxy-17a-methyl-testosteron und -19-nortestosteron | |
| DE1039514B (de) | Verfahren zur Herstellung von Steroidverbindungen | |
| DD268953A1 (de) | Verfahren zur herstellung von 3-alkoxy-13beta-alkyl-gona-2,5(10)-dien-17beta-ol-derivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |